Catalytic Oligotherapy

According to catalytic oligotherapy, modern living conditions, disease, food, air and drug pollution result in a phenomena that blocks trace elements in the body, with the total or partial inactivation of enzymes, that are controlled by them. This phenomenon is called “chelation.” The pathological symptoms of the disease would originate from these blockages.


Nutritional Oligotherapy

Historically nutritional oligotherapy is the second form of systematic use of mineral elements. It developed in the 60s thanks to the remarkable advances in Food Science that determined the role of the various trace elements and their needs.

More recently Orthomolecular Medicine and Nutritherapy have developed. The object of study of these disciplines is the study of the role of essential micronutrients (trace elements, vitamins, amino acids and essential fatty acids) and their administration in case of shortage.


Pharmaceutical Oligotherapy

This is the most recent form of therapeutic use of mineral elements. It is based on the use of much higher levels of concentrations of trace elements with respect to catalytic and nutrition.

Upon examining a graph that shows the optimal biological activity of a trace element based on its intake and its concentration, one can detect the presence of a zone, called “ergotropic”, interposed between optimum intake and toxicological area, which corresponds to the pharmacological effect.

Some examples of clinical utilization of pharmacology oligotherapy are those that use Fluorine in the treatment of osteoporosis, zinc sulfate in the treatment of psoriatic arthritis and in the treatment of Wilson’s disease or disease from Copper, in association with Novocaine and sodium salicylate in the treatment of rheumatoid arthritis.